How Your Liver Processes a New Injection Medicine
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how your body processes a new medicine called HRS9531 when injected. Researchers want to understand how liver function affects the medicine's breakdown, which helps them determine safe doses for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Weigh at least 50 kg (men) or 45 kg (women), with a healthy BMI
- Not be pregnant, planning pregnancy, or breastfeeding during the study and for 2 months after your last dose
- Not have participated in another drug trial within the past 3 months
- Be willing to avoid smoking, alcohol, and recreational drugs during the study
- Not have had major surgery in the past 6 months or planned during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new medicine (SHR-3167) is absorbed by the body and checks for side effects. Healthy volunteers ages 18-55 can join to help researchers understand how this drug works.
This study is testing a new injectable medicine (HRS-4729) to see how the body processes it in people with healthy kidneys and in those with kidney problems. If you join, you will receive a single dose and have your blood and urine checked over time to measure the drug levels.
This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests how a new tablet (called HRS9531) is absorbed and processed by the body under different conditions (like with or without food). It is for healthy volunteers to find the best way to take the tablet.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.